首页> 外文OA文献 >Cystatin C is a reliable marker for estimation of glomerular filtration rate in renal transplantation: validation of a new turbidimetric assay using monospecific sheep antibodies
【2h】

Cystatin C is a reliable marker for estimation of glomerular filtration rate in renal transplantation: validation of a new turbidimetric assay using monospecific sheep antibodies

机译:Cystatin C是评估肾移植中肾小球滤过率的可靠标志物:使用单特异性绵羊抗体的新型比浊法验证

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: The potential use of Cystatin C was recently assessed in kidney transplantation.A new particle-enhanced turbidimetric immunoassay (PETIA) that uses sheep antibodies(Binding Site Human Cystatin C immunoassay) has been developed. Analytical performanceof this new assay was evaluated. Clinical relevance was determined by comparison with areference method in a cohort of kidney transplant patients.Patients and methods: First, the analytical performance of the Binding Site cystatin C kitwas tested on SPAPLUS® and Hitachi® analyzers. Second, a comparison study was performedusing SPAPLUS® analyzer against two other cystatin C methods (the Siemens-PENIA methodon BNII® and the Dako-PETIA application on Olympus AU640®). Third, the glomerularfiltration rate (GFR) was estimated using several predictive cystatin C- and creatinine-basedequations and compared to GFR measured by an isotopic method (99mTc-DTPA). Thesepredictive algorithms were analyzed with respect to bias, precision and accuracy.Results: Total intra-assay and inter-assay coefficients of variation were below 5%. Valuesobtained with the SPAPLUS® correlated with the Siemens-PENIA and the Dako-PETIAmethods. The creatinine and cystatin C-based equation allowed reliable assessment of GFR inour population of renal transplantation.Conclusions: The use of algorithms based on cystatin C and creatinine could provide areliable estimate of GFR in kidney transplantation.
机译:背景:最近研究评估了胱抑素C在肾脏移植中的潜在用途。已开发出一种新的使用绵羊抗体的颗粒比浊法(PETIA)(结合位点人类胱抑素C免疫法)。评价了该新测定法的分析性能。通过与参考方法比较在一组肾脏移植患者中的临床相关性。患者和方法:首先,在SPAPLUS®和Hitachi®分析仪上测试了Binding Site cystatin C kit的分析性能。其次,使用SPAPLUS®分析仪与其他两种胱抑素C方法(BNII®上的Siemens-PENIA方法和OlympusAU640®上的Dako-PETIA应用程序)进行了比较研究。第三,使用几种基于胱抑素C和肌酐的预测方程估算肾小球滤过率(GFR),并将其与通过同位素法(99mTc-DTPA)测量的GFR进行比较。分析了这些预测算法的偏倚,准确性和准确性。结果:总的批内和批间变异系数低于5%。 SPAPLUS®获得的价值与Siemens-PENIA和Dako-PETIA方法相关。结论:基于半胱氨​​酸蛋白酶抑制剂C和肌酐的算法可以为肾脏移植中的肾小球滤过率提供可靠的估计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号